Vitamin D3 binding activity during leukemic cell differentiation.
In this paper we report that differentiation of the human promyelocytic leukemia cell line, HL60, along the myelocytic pathway, induced by retinoic acid (RA), or monocytic pathway, induced by phorbol-myristate acetate (PMA) and gamma interferon (IFN), was accompanied by a significant decline in 1,25-dihydroxycholecalciferol (1,25(OH)2D3) binding (control: 30.3 +/- 3.0 fM/10(6) cells; RA treated: 6.8 + 2.5 fM/10(6) cells; PMA treated: 12.3 +/- 6.7 fM/10(6) cells and IFN treated: 16.0 +/- 5.0 fM/10(6) cells). When differentiation and proliferation were uncoupled, by incubation with IFN or by inhibition of proliferation by cell density saturation, 1,25(OH)2D3 binding was better related to differentiation than to proliferation. Additionally we have compared 1,25(OH)2D3 binding levels in blasts from acute lymphocytic leukemia (ALL) patients (25.4 +/- 18.1 fM/10(6) cells) and normal, mature lymphocytes (10.6 +/- 2.1 fM/10(6) cells). Receptor binding was significantly higher (p < 0.05) in the immature blasts. Our data suggest that 1,25(OH)2D3 receptor levels could be considered a marker of functional immaturity, in these cells.
Feldman
J
J
Departamento de Clínica Médica, Faculdade de Medicina, Universidade de São Paulo, Brasil.
Federico
M H
MH
Sonohara
S
S
Katayama
M L
ML
Koike
M A
MA
Roela
R A
RA
da Silva
M R
MR
Brentani
M M
MM
D002117:Calcitriol / Q000378:metabolism*; D002454:Cell Differentiation; D006801:Humans; D007372:Interferons / Q000494:pharmacology; D015473:Leukemia, Promyelocytic, Acute / Q000378:metabolism* / Q000473:pathology*; D018167:Receptors, Calcitriol; D011987:Receptors, Steroid / Q000032:analysis* / Q000502:physiology; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D014212:Tretinoin / Q000494:pharmacology; D014407:Tumor Cells, Cultured
D018167:Receptors, Calcitriol; D011987:Receptors, Steroid; D014212:Tretinoin; D007372:Interferons; D002117:Calcitriol; D013755:Tetradecanoylphorbol Acetate